STERIS plc — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2021-06-02

Reporting Person: Madsen Julia (Senior VP, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-02	Ordinary Shares	A	1440	$0.00	Acquired	5857	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-02	Employee Stock Option (right to buy)	$210.30	M	7604	Acquired	2031-06-02	Ordinary Shares (7604)	Direct

Footnotes

F1: All 1,440 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 360 on June 2, 2023; 360 on June 3, 2024 and 360 on June 2, 2025.

F2: 3,510 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 June 2, 2023; 349 on October 2, 2023; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024 and 360 on June 2, 2025.

F3: This option becomes exercisable as follows: 1,901 on June 2, 2022; 1,901 on June 2, 2023; 1,901 on June 3, 2024 and 1,901 on June 2, 2025.